Status:
UNKNOWN
Outcomes of Endovascular Treatment of Superficial Femoral Artery In-stent Restenosis
Lead Sponsor:
Assiut University
Conditions:
Peripheral Arterial Disease
Eligibility:
All Genders
16-90 years
Phase:
NA
Brief Summary
Lower limb peripheral arterial disease (PAD) is a common, important manifestation of systemic atherosclerosis. Stenosis or occlusions in the superficial femoral artery (SFA) may result in intermittent...
Eligibility Criteria
Inclusion
- \- Patients with PAD undergoing peripheral vascular intervention with SFA in stent stenosis for two years from the start of study and has critical limb ischemia.
Exclusion
- Refusal of the patients
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04123639
Start Date
October 1 2019
End Date
October 1 2022
Last Update
October 11 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut university hospital
Asyut, Egypt